UFlex Q1 FY27: Margin expansion meets global capacity ramp-up

UFlex started FY27 with a sharp improvement in profitability. Consolidated revenue in Q1 FY27 was Rs. 53,972 million, up 37.6 percent year on year, while EBITDA rose to Rs. 9,198 million, up 92.1 percent. EBITDA margin expanded to 17.0 percent, compared to 12.2 percent a year ago. Normalized profit after tax was Rs. 4,233 million, translating to a 7.8 percent margin.

The quarter’s narrative combined strong pricing and better utilization, with overseas operations playing an outsized role. Management attributed performance to operating leverage, stronger realizations, a shift towards value-added packaging films, and localized sourcing premiums in several markets. The backdrop was also unusual: the company repeatedly referred to the West Asia crisis, which has disrupted raw material production and trade routes, lifting freight costs and altering buyer behavior.

What moved the numbers in Q1 FY27

A key feature of the quarter was the change in geographical mix. Revenue was split 41.3 percent from India and 58.7 percent from overseas operations, based on point of origin. The company also highlighted that incremental revenue was led by overseas businesses. In the conference call, management said overseas operations contributed around 80 percent of incremental revenue and around 91 percent of incremental EBITDA.

By business line, packaging films including PET chips remained the core engine. Packaging volumes declined year on year, which the company described as partly strategic: domestic flexible packaging was tilted toward higher-margin products, while aseptic packaging faced aggressive duty-free imports in India and shipment disruptions in overseas markets.

Financial summary (consolidated)

Note: Figures are converted from Rs. million to INR crore. Net debt is shown for Q1 FY27 and Q1 FY26 as presented.

Revenue mix: films dominate, while geography shifts outward

UFlex’s Q1 FY27 revenue from operations was Rs. 53,660 million. The business mix shows a heavier tilt toward packaging films including PET chips.

Geographically, India’s revenue share reduced versus Q1 FY26, while Middle East and Africa increased to 20.6 percent. Management described a clear driver: customers, especially in MEA, were prioritizing local and regional sourcing as they de-risked supply chains amid the West Asia conflict.

Capacity utilization and the playbook of being near the customer

The presentation includes a detailed view of packaging films production across geographies. Total packaging film production rose to 135,873 MT in Q1 FY27 versus 126,076 MT in Q4 FY26, with overall utilization improving to 85.4 percent. The company has manufacturing sites across India, Dubai, Egypt, Nigeria, CIS, Poland, Hungary, USA and Mexico.

Management repeatedly emphasized a strategy of serving customers from nearby manufacturing hubs. The rationale is practical: when shipping lanes are disrupted, a geographically diversified footprint can protect volumes, reduce delivery risk, and support pricing premiums.

This positioning also connects to the company’s discussion on pricing. In the call, the CFO said BOPP prices were up around 25 to 32 percent and BOPET prices were up around 30 to 35 percent from February 2026 levels. While raw material prices also moved up, management suggested finished goods prices increased faster in Q1.

Capex update: two projects commissioned, one large commissioning next

UFlex reported Q1 FY27 capex of Rs. 4,782 million, directed mainly to four projects: the Egypt aseptic line, the Mexico WPP bags plant, the Noida Sector 155 recycling unit, and the Dharwad BOPP line.

Two projects are already commissioned.

First, the Noida Sector 155 recycling facility, with capacity of 39,600 MTPA, was commissioned on April 30, 2026. The sustainability section frames recycling as a long-running platform branded as Project Plastic Fix. The company disclosed that in Q1 FY27 it recycled 319 million post-consumer PET bottles and 2,926 MT of post-consumer MLP waste.

Second, the Mexico WPP bags facility, with 80 million units capacity, was commissioned on July 31, 2026.

The next major commissioning is the greenfield aseptic project in Ain Sukhna, Egypt, with annual capacity of 12 billion packs. The presentation shows residual capex of Rs. 1,630 million as of June 2026 and commissioning targeted in H1 FY27E. On the call, management said trials and approvals are advanced and discussed a ramp trajectory, with around 30 percent utilization in the first year after start.

Key risks management highlighted

While the quarter was strong, the documents do not present it as risk-free.

The West Asia conflict is described as disrupting feedstock production and transit routes, increasing freight costs, and tightening supply for imported raw materials such as MEG and polypropylene. Management also highlighted that shipment timing can create quarter-on-quarter volatility.

Aseptic packaging demand faced pressure from aggressive duty-free imports in India. Management mentioned Indonesia specifically, though it also argued that India’s consumer market is growing and that demand should rise over time.

Finally, net debt increased year on year to Rs. 85,875 million in Q1 FY27 from Rs. 73,055 million in Q1 FY26. Management said net debt to EBITDA has improved due to higher earnings and targeted further reduction as new capacities ramp. It also stated an expectation to reduce interest costs by at least 1 percent over the next year.

Takeaways

UFlex’s Q1 FY27 results reflect a combination of higher realizations, improved utilization, and a meaningful contribution from overseas businesses. The company’s operating model, built around manufacturing across regions close to customers, has been positioned as a structural advantage during a period of disrupted trade routes.

The next swing factor is execution and ramp-up. Two projects have already been commissioned and management expects progressive contribution from them. The Egypt aseptic commissioning remains a key near-term milestone, with management indicating it can be a material revenue and margin driver once commercial production begins and utilization scales.